Background: Although research interest in social phobias has expanded during the last decade, a special subtype of social phobia known as paruresis, which manifests in the inability to urinate in public rest rooms, is rarely mentioned. The aim of the present study was to achieve for the first time an estimation of point prevalence in a representative male sample (n = 1,105). Method: Due to the lack of well-established screening instruments for paruresis, the Paruresis Checklist (PCL) must be tested for reliability and validity. An empirically based cutoff score must be determined by using the subjective interference with everyday life as an external criterion. Results: Reliability of the PCL seemed to be sufficient, and adequate evidence for validity was found. Using the empirically based cutoff score of the PCL, 2.8% of the sample was diagnosed as suffering from paruresis. In contrast to other forms of social phobia, paruresis is not associated with a lower educational or occupational level.

Keywords:
Paruresis, Social anxiety, Epidemiology
1.
Williams GW, Degenhardt ET: Paruresis: A survey of a disorder of micturition. J Gen Psychology 1954;51:19–29.
2.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Text Revision (DSM-IV-TR). Washington, American Psychiatric Association, 2003.
3.
Margolis GJ: A review of literature on psychogenic urinary retention. J Urol 1965;94:257–258.
4.
Moutier CY, Stein MB: The history, epidemiology, and differential diagnosis of social anxiety disorder. J Clin Psychiatry 1999;60(suppl 9):4–8.
5.
Pollack MH: Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. J Clin Psychiatry 2001;62(suppl 12):24–29.
6.
Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Bobes J, Beidel DC, Ono Y, Westenberg HG: Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 1998;59(suppl 17):54–60.
7.
Vythilingum B, Stein DJ, Soifer S: Is ‘shy bladder syndrome’ a subtype of social anxiety disorder? A survey of people with paruresis. Depress Anxiety 2002;16:84–87.
8.
Watson TS, Freeland JT: Treating paruresis using respondent conditioning. J Behav Ther Exp Psychiatry 2001;31:155–162.
9.
Marks IM: Fears, Phobias, and Rituals. Panic, Anxiety, and Their Disorders. New York, Oxford University Press, 1987.
10.
Wahl CW, Golden JS: Psychogenic urinary retention report of 6 cases. Psychosom Med 1963;25:543–555.
11.
Chapman AH: Psychogenic urinary retention in women: Report of a case. Psychosom Med 1959;21:119–122.
12.
Lamontagne Y, Marks IM: Psychogenic urinary retention: Treatment by prolonged exposure. Behav Ther 1973;4:581–585.
13.
Hammelstein P, Jäntsch B, Barnett W: Paruresis – ein bisher vernachlässigtes psychotherapeutisches Problem. Psychotherapeut 2003;48:260–263.
14.
McCracken LM, Larkin KT: Treatment of paruresis with in vivo desensitization: A case report. J Behav Ther Exp Psychiatry 1991;22:57–62.
15.
Jaspers JPC: Cognitive-behavioral therapy for paruresis: A case report. Psychol Rep 1998;83:187–196.
16.
Bohn P, Sternbach H: Current knowledge and research directions in the treatment of paruresis. Depress Anxiety 1997;5:41–42.
17.
Nicolau R, Toro J, Perez Prado C: Behavioral treatment of a case of psychogenic urinary retention. J Behav Ther Exp Psychiatry 1991;22:63–68.
18.
Hatterer JA, Gorman JM, Fyer AJ, Campeas RB: Pharmacotherapy of four men with paruresis. Am J Psychiatry 1990;147:109–111.
19.
Zgourides GD: Paruresis: Overview and implications for treatment. Psychol Rep 1987;60:1171–1176.
20.
Allen TD: Psychogenic urinary retention. South Med J 1972;65:302–304.
21.
Christmas TJ, Noble JG, Watson GM, Turner-Warwick RT: Use of biofeedback in treatment of psychogenic voiding dysfunction. Urology 1991;37:43–45.
22.
Wheeler JS, Renshaw D: Psychogenic urinary retention in a male. Br J Urol 1995;76:669–670.
23.
Tu RK: Psychogenic urinary retention (Hinman syndrome) in a child. AJR Am J Roentgenol 1992;158:460–461.
24.
Khan AU: Psychogenic urinary retention in a boy. J Urol 1971;106:432–434.
25.
Nesbitt RE Jr, Hollender MH, Feldman PM, Glazer JA, Hayes RC, Ferro PL: Psychogenic urinary retention. Int Psychiatry Clin 1965;2:561–582.
26.
Soifer S, Zgourides G, Himle J, Pickering NL: Shy Bladder Syndrome. Oakland, New Harbinger Publications, 2001.
27.
Malouff JM, Lanyon RI: Avoidant paruresis: An exploratory study. Behav Modif 1985;9:225–234.
28.
Hammelstein P: Paruresis: Bemerkungen zur Ätiologie und verhaltenstherapeutischen Behandlung. Verhaltenstherapie 2002;12:224–227.
29.
Wittchen HU: Continued needs for epidemiological studies of mental disorders in the community. Psychother Psychosom 2004;73:197–206.
30.
Pollard CA, Henderson JG: Four types of social phobia in a community sample. J Nerv Ment Dis 1988;176:440–445.
31.
Rees B, Leach D: The social inhibition of micturition (paruresis): Sex similarities and differences. J Am Coll Health Assoc 1975;23:203–205.
32.
Gruber DL, Shupe DR: Personality correlates of urinary hesitancy (paruresis) and body shyness in male college students. J Coll Stud Pers 1982;23:308–313.
33.
Kessler RC, Stein MB, Berglund P: Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatry 1998;155:613–619.
34.
First MB, Gibbon M, Spitzer RL, Williams JBW: User’s Guide for the Structured Clinical Interview for DSM-IV Axis 1 Disorders – Research Version. Washington, American Psychiatric Press, 1996.
35.
Rumpf H-J, Löntz W, Uesseler S: A self-administered version of a brief measure of suffering: First aspects of validity. Psychother Psychosom 2004;73:53–56.
36.
Faravelli C, Abrardi L, Bartolozzi D, Cecchi C, Cosci F, D’Adamo D, Iacono BL, Ravaldi C, Scarpato MA, Truglia E, Prodi PMR, Rosi S: The Sesto Fiorentino study: Point and one-year prevalences of psychiatric disorders in an Italian community sample using clinical interviewers. Psychother Psychosom 2004;73:226–234.
37.
Löwe B, Spitzer RL, Zipfel S, Herzog W: PHQ-D. Gesundheitsfragebogen für Patienten. Karlsruhe, Pfizer, 2002.
38.
Spitzer RL, Williams JBW, Kroenke K, Linzer M, deGruy FV, Hahn SR, Brody D, Johnson JG: Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749–1756.
39.
Spitzer RL, Kroenke K, Williams JBW: Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. JAMA 1999;282:1737–1744.
40.
Hamilton M: A rating scale for depression. J Neurol Neurosur Psychiatry 1960;23:56–62.
41.
Bonsignore M, Barkow K, Jessen F, Heun R: Validity of the five-item WHO Well-Being Index (WHO-5) in an elderly population. Eur Arch Psychiatry Clin Neurosci 2001;251(suppl 2):II/27–II/31.
42.
Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W: Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 2004;78:131–140.
43.
Henkel V, Mergl R, Kohnen R, Maier W, Möller HJ, Hegerl U: Identifying depression in primary care: A comparison of different methods in a prospective cohort study. BMJ 2003;326:200–201.
44.
Epstein DH: Problems with odds ratios. Am J Psychiatry 2003;160:190–191.
45.
Bovasso GB: Problems with odds ratios. Reply. Am J Psychiatry 2003;160:191.
46.
Davies HTO, Corombie IK, Tavakoli M: When can odds ratios mislead? BMJ 1998;316:989–991.
47.
Faravelli C: Assessment of psychopathology. Psychother Psychosom 2004;73:139–141.
48.
Faravelli C, Abrardi L, Bartolozzi D, Cecchi C, Cosci F, D’Adamo D, Iacono BL, Ravaldi C, Scarpato MA, Truglia E, Rosi S: The Sesto Fiorentino study: Background, methods and preliminary results. Psychother Psychosom 2004;73:216–225.
49.
Westenberg HG: The nature of social anxiety disorder. J Clin Psychiatry 1998;59(suppl 17):20–26.
50.
Stein MB, Kean YM: Disability and quality of life in social phobia: Epidemiologic findings. Am J Psychiatry 2000;157:1606–1613.
51.
Lang AJ, Stein MB: Social phobia: prevalence and diagnostic threshold. J Clin Psychiatry 2001;62(suppl 1):5–10.
52.
Brunello N, den-Boer JA, Judd LL, Kasper S, Kelsey JE, Lader M, Lecrubier Y, Lepine JP, Lydiard RB, Mendlewicz J, Montgomery SA, Racagni G, Stein MB, Wittchen H-U: Social phobia: Diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J Affect Disord 2000;60:61–74.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.